Kamada (KMDA) EBIT Growth (3y) (2015 - 2026)
Kamada (KMDA) EBIT Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 4.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 40.17% |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -71.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -71.13% |
| Dec 31, 2025 | 28.03% |
| Sep 30, 2025 | -83.12% |
| Jun 30, 2025 | 1,920.91% |
| Mar 31, 2025 | 216.44% |
| Dec 31, 2024 | 70.09% |
| Sep 30, 2024 | 142.06% |
| Jun 30, 2024 | 75.35% |
| Mar 31, 2024 | 4.95% |
| Dec 31, 2023 | -10.60% |
| Sep 30, 2023 | 687.56% |
| Jun 30, 2023 | -20.24% |
| Mar 31, 2023 | 268.15% |
| Dec 31, 2022 | -9.85% |
| Sep 30, 2022 | 666.14% |
| Jun 30, 2022 | -33.12% |
| Mar 31, 2022 | -66.12% |
| Dec 31, 2021 | -30.35% |
| Sep 30, 2021 | 31.71% |
| Jun 30, 2021 | -41.30% |